Literature DB >> 25053862

The state of irreversible electroporation in interventional oncology.

Mikhail Silk1, David Tahour1, Govindarajan Srimathveeravalli1, Stephen B Solomon1, Raymond H Thornton1.   

Abstract

A new ablation modality, irreversible electroporation (IRE), has been of increasing interest in interventional radiology. Its nonthermal mechanism of action of killing tumor cells allows physicians the ability to ablate tumors in areas previously contraindicated for thermal ablation. This article reviews the current published clinical outcomes, imaging follow-up, and the current knowledge gaps in the procedure for patients treated with IRE.

Entities:  

Keywords:  ablation; interventional oncology; interventional radiology; irreversible electroporation; kidney; liver; lung; pancreas

Year:  2014        PMID： 25053862      PMCID： PMC4078112          DOI： 10.1055/s-0034-1373785

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  38 in total

1.  Percutaneous radiofrequency ablation does not affect glomerular filtration rate.

Authors:  Joseph A Pettus; David M Werle; Weston Saunders; Ashok Hemal; Andrew Karim Kader; David Childs; Ronald J Zagoria
Journal:  J Endourol       Date:  2010-10       Impact factor: 2.942

2.  Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma.

Authors:  Ronald J Zagoria; Joseph A Pettus; Morgan Rogers; David M Werle; David Childs; John R Leyendecker
Journal:  Urology       Date:  2011-04-13       Impact factor: 2.649

3.  Irreversible electroporation: implications for prostate ablation.

Authors:  Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

Review 4.  Microsecond and nanosecond electric pulses in cancer treatments.

Authors:  Marie Breton; Lluis M Mir
Journal:  Bioelectromagnetics       Date:  2011-08-03       Impact factor: 2.010

5.  Irreversible electroporation ablation: is all the damage nonthermal?

Authors:  Mohammad Faroja; Muneeb Ahmed; Liat Appelbaum; Eliel Ben-David; Marwan Moussa; Jacob Sosna; Isaac Nissenbaum; S Nahum Goldberg
Journal:  Radiology       Date:  2012-11-20       Impact factor: 11.105

6.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Authors:  T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong
Journal:  J Am Coll Surg       Date:  2012-06-16       Impact factor: 6.113

7.  Irreversible electroporation: a new challenge in "out of operating theater" anesthesia.

Authors:  Christine Ball; Kenneth R Thomson; Helen Kavnoudias
Journal:  Anesth Analg       Date:  2010-02-08       Impact factor: 5.108

8.  Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.

Authors:  Ephrem O Olweny; Payal Kapur; Yung K Tan; Samuel K Park; Mehrad Adibi; Jeffrey A Cadeddu
Journal:  Urology       Date:  2013-01-03       Impact factor: 2.649

9.  Percutaneous ablation of peribiliary tumors with irreversible electroporation.

Authors:  Mikhail T Silk; Thomas Wimmer; Kyungmouk S Lee; Govindarajan Srimathveeravalli; Karren T Brown; Peter T Kingham; Yuman Fong; Jeremy C Durack; Constantinos T Sofocleous; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2013-11-18       Impact factor: 3.464

10.  Irreversible electroporation: an in vivo study with dorsal skin fold chamber.

Authors:  Zhenpeng Qin; Jing Jiang; Gary Long; Bruce Lindgren; John C Bischof
Journal:  Ann Biomed Eng       Date:  2012-11-22       Impact factor: 3.934
View more
  17 in total

1.  The Feasibility of Combined Microwave Ablation and Irreversible Electroporation for Central Liver Metastase.

Authors:  Julia Weiss; Julien Garnon; Danoob Dalili; Roberto Luigi Cazzato; Guillaume Koch; Pierre Auloge; Afshin Gangi
Journal:  Cardiovasc Intervent Radiol       Date:  2021-03-03       Impact factor: 2.740

2.  Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.

Authors:  Stefan Fritz; Christof M Sommer; Thomas Longerich; Clemens Kuhn-Neureuther; Boris Radeleff; Jens Werner; Thilo Hackert
Journal:  Langenbecks Arch Surg       Date:  2017-04-04       Impact factor: 3.445

3.  Percutaneous irreversible electroporation for the treatment of small renal masses: The first Canadian case series.

Authors:  Bonnie Liu; Jordyn Clark; Trustin Domes; Chris Wall; Kunal Jana
Journal:  Can Urol Assoc J       Date:  2019-01-21       Impact factor: 1.862

Review 4.  Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.

Authors:  John Withington; Joana B Neves; Ravi Barod
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

Review 5.  Trial Watch: Adoptively transferred cells for anticancer immunotherapy.

Authors:  Carole Fournier; François Martin; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Lionel Apetoh
Journal:  Oncoimmunology       Date:  2017-08-11       Impact factor: 8.110

6.  Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Authors:  Mao Lin; Shuzhen Liang; Xiaohua Wang; Yinqing Liang; Mingjie Zhang; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-04       Impact factor: 4.553

7.  Catheter-based endobronchial electroporation is feasible for the focal treatment of peribronchial tumors.

Authors:  Hiroshi Kodama; Laurien G Vroomen; Eisuke Ueshima; Jennifer Reilly; Whitney Brandt; Lee-Ronn Paluch; Sebastien Monette; David Jones; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-20       Impact factor: 5.209

8.  DWI and DCE-MRI approaches for differentiating reversibly electroporated penumbra from irreversibly electroporated ablation zones in a rabbit liver model.

Authors:  Anna J Shangguan; Chong Sun; Bin Wang; Liang Pan; Quanhong Ma; Su Hu; Jia Yang; Aydin Eresen; Yuri Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

9.  Ureteral Stent Fracture After Irreversible Electroporation for Treatment of Metastatic Rectal Adenocarcinoma.

Authors:  Harjivan Kohli; Alexander Tapper; James Relle
Journal:  J Endourol Case Rep       Date:  2020-12-29

Review 10.  Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria.

Authors:  Yanzhao Zhou; Yi Yang; Bingyan Zhou; Zhengzheng Wang; Ruili Zhu; Xun Chen; Jingzhong Ouyang; Qingjun Li; Jinxue Zhou
Journal:  J Hepatocell Carcinoma       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.